Literature DB >> 1745490

Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

K Isono1, H Sato, K Nakayama.   

Abstract

In order to determine the operative indications of three-field lymph node dissection of esophageal cancer, attempts were made to collect data concerning procedures performed between 1983 and 1989 in major institutions in Japan, and the results from institutions performing three-field or two-field lymph node dissection were compared. The treatment results of three-field lymph node dissection were better than those after two-field dissection, except for early or advanced cancer. The survival rate improved by the three-field as compared with the two-field lymph node dissection; however, since surgery was invasive, some complications such as recurrent nerve paralysis were frequent. The results show that the indication of three-field lymph node dissection has to be carefully determined for each patient.

Entities:  

Mesh:

Year:  1991        PMID: 1745490     DOI: 10.1159/000226971

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  127 in total

1.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma.

Authors:  Youtao Xu; Jie Wang; Mantang Qiu; Lei Xu; Ming Li; Feng Jiang; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2014-10-31

2.  Multimodality treatments with endoscopic mucosal resection of esophageal squamous cell carcinoma with submucosal invasion.

Authors:  M Ota; H Ide; K Hayashi; Y Murata; R Eguchi; T Nakamura; K Narumiya; I Oi; K Takasaki
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

3.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

4.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

5.  Recurrent laryngeal nerve monitoring during esophagectomy and mediastinal lymph node dissection: a novel approach using a single-lumen endotracheal EMG tube and the EZ-blocker.

Authors:  Joachim Schmidt; Andrea Irouschek; Sebastian Heinrich; Oliver Oster; Peter Klein; Torsten Birkholz
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

6.  [Preoperative evaluation of prognostic factors in esophageal squamous cell cancer].

Authors:  P M Schneider; D Vallböhmer; J Brabender; A H Hölscher
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

7.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 8.  Surgical management of esophageal malignancy.

Authors:  Dennis Blom
Journal:  Curr Gastroenterol Rep       Date:  2003-06

9.  Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Authors:  Yaping Xu; Qixun Chen; Xinmin Yu; Ximing Zhou; Xiao Zheng; Weimin Mao
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

10.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.